Neuphoria Therapeutics Statistics

Total Valuation

NEUP has a market cap or net worth of $10.16 million. The enterprise value is $5.87 million.

Market Cap	10.16M
Enterprise Value	5.87M

Important Dates

The next estimated earnings date is Thursday, May 15, 2025, before market open.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

NEUP has 1.76 million shares outstanding. The number of shares has increased by 126.50% in one year.

Current Share Class	1.76M
Shares Outstanding	1.76M
Shares Change (YoY)	+126.50%
Shares Change (QoQ)	-99.94%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	11.95%
Float	723,231

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.17
Forward PS	n/a
PB Ratio	0.68
P/TBV Ratio	49.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.01.

Current Ratio	2.06
Quick Ratio	2.05
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.98% and return on invested capital (ROIC) is -53.32%.

Return on Equity (ROE)	-48.98%
Return on Assets (ROA)	-41.53%
Return on Invested Capital (ROIC)	-53.32%
Return on Capital Employed (ROCE)	-92.53%
Revenue Per Employee	$27,613
Profits Per Employee	-$342,221
Employee Count	24
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	-138,311
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	4.90
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.24
Average Volume (20 Days)	47,777

Short Selling Information

The latest short interest is 49,711, so 2.83% of the outstanding shares have been sold short.

Short Interest	49,711
Short Previous Month	71,798
Short % of Shares Out	2.83%
Short % of Float	6.87%
Short Ratio (days to cover)	0.06

Income Statement

In the last 12 months, NEUP had revenue of $662,715 and -$8.21 million in losses. Loss per share was -$0.00.

Revenue	662,715
Gross Profit	2.15M
Operating Income	-14.84M
Pretax Income	n/a
Net Income	-8.21M
EBITDA	-14.39M
EBIT	-14.84M
Loss Per Share	-$0.00

Full Income Statement

Balance Sheet

The company has $4.34 million in cash and $168,310 in debt, giving a net cash position of $4.18 million or $2.38 per share.

Cash & Cash Equivalents	4.34M
Total Debt	168,310
Net Cash	4.18M
Net Cash Per Share	$2.38
Equity (Book Value)	13.75M
Book Value Per Share	8.44
Working Capital	2.26M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-14.10M
Capital Expenditures	n/a
Free Cash Flow	-14.10M
FCF Per Share	-$8.02

Full Cash Flow Statement

Margins

Gross Margin	324.11%
Operating Margin	-2,238.73%
Pretax Margin	-1,260.21%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NEUP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-126.50%
Shareholder Yield	-126.50%
Earnings Yield	-81.72%
FCF Yield	-140.27%

Analyst Forecast

The average price target for NEUP is $21.00, which is 263.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	263.32%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NEUP has an Altman Z-Score of -15.46 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.46
Piotroski F-Score	1